Engineered t cells take on stubborn germ cell tumors
NCT ID NCT05634785
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 26 times
Summary
This study tested a new treatment for a rare type of testicular cancer called nonseminomatous germ cell tumors. Researchers took patients' own immune cells (T cells) and modified them to recognize and attack cancer cells that carry a protein called CD30. The goal was to see if these modified cells could shrink tumors and how long they lasted in the body. Only 2 adults took part, and the study focused on safety and building a biobank for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.